Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 27 10 2020
revised: 02 03 2021
accepted: 19 03 2021
pubmed: 27 3 2021
medline: 15 5 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

Investigations demonstrated a decrease of admissions for myocardial infarction (MI) during the CoronaVirus Disease-19 (COVID-19) outbreak. No study has evaluated the time required to reverse this downward curve of MI admissions. This is a retrospective analysis on patients (N = 2415) admitted to the Emergency Departments for acute MI in nine Italian centers. Primary endpoint was the incidence rates (IRs) of MI admissions in the post-lockdown COVID-19 period (case-period: from May 4 to July 12, 2020) vs. the following control periods: January 1-February 19, 2020 (pre-lockdown period); February 20-May 3, 2020 (intra-lockdown period); May 4-July 12, 2019 (inter-year non-COVID-19 period). IR of admissions for MI in the post-lockdown period was higher than the intra-lockdown period (IR ratio, IRR: 1.60, 95% CI 1.42-1.81; p = 0.0001), was lower than the pre-lockdown period (IRR: 0.86, 0.77-0.96; p = 0.009) and similar to the inter-year non-COVID-19 period (IRR: 0.96, 0.87-1.07; p = 0.47). Within the case period, the increase in MI admissions was more pronounced in earlier vs later weeks (IRR 1.19, 95% CI 1.02-1.38, p = 0.024) and, compared to the inter-year control period, was significant for non ST-segment elevation MI (IRR: 1.25, 95% CI 1.08-1.46, p = 0.004), but was not observed for ST-segment elevation MI (STEMI), where hospitalizations were reduced (IRR 0.76, 95% CI 0.65-0.88, p = 0.0001). Our study first indicates an increase in the number of admissions for MI after the removal of the national lockdown for COVID-19 in Italy. This increase was prevalent in the first weeks following the lockdown removal, but was under-represented in STEMI patients.

Sections du résumé

BACKGROUND
Investigations demonstrated a decrease of admissions for myocardial infarction (MI) during the CoronaVirus Disease-19 (COVID-19) outbreak. No study has evaluated the time required to reverse this downward curve of MI admissions.
METHODS
This is a retrospective analysis on patients (N = 2415) admitted to the Emergency Departments for acute MI in nine Italian centers. Primary endpoint was the incidence rates (IRs) of MI admissions in the post-lockdown COVID-19 period (case-period: from May 4 to July 12, 2020) vs. the following control periods: January 1-February 19, 2020 (pre-lockdown period); February 20-May 3, 2020 (intra-lockdown period); May 4-July 12, 2019 (inter-year non-COVID-19 period).
RESULTS
IR of admissions for MI in the post-lockdown period was higher than the intra-lockdown period (IR ratio, IRR: 1.60, 95% CI 1.42-1.81; p = 0.0001), was lower than the pre-lockdown period (IRR: 0.86, 0.77-0.96; p = 0.009) and similar to the inter-year non-COVID-19 period (IRR: 0.96, 0.87-1.07; p = 0.47). Within the case period, the increase in MI admissions was more pronounced in earlier vs later weeks (IRR 1.19, 95% CI 1.02-1.38, p = 0.024) and, compared to the inter-year control period, was significant for non ST-segment elevation MI (IRR: 1.25, 95% CI 1.08-1.46, p = 0.004), but was not observed for ST-segment elevation MI (STEMI), where hospitalizations were reduced (IRR 0.76, 95% CI 0.65-0.88, p = 0.0001).
CONCLUSIONS
Our study first indicates an increase in the number of admissions for MI after the removal of the national lockdown for COVID-19 in Italy. This increase was prevalent in the first weeks following the lockdown removal, but was under-represented in STEMI patients.

Identifiants

pubmed: 33766626
pii: S0167-5273(21)00550-7
doi: 10.1016/j.ijcard.2021.03.046
pmc: PMC7983363
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-237

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
BMC Infect Dis. 2010 May 28;10:139
pubmed: 20509887
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131

Auteurs

Andrea Rognoni (A)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Fabrizio D'Ascenzo (F)

Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy; Department of Medical Sciences, University of Torino, Torino, Italy.

Martina Solli (M)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Marco G Mennuni (MG)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Vincenzo Galiffa (V)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Roberta Rosso (R)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Chiara Cavallino (C)

Division of Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy.

Fabrizio Ugo (F)

Division of Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy.

Ovidio De Filippo (O)

Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.

Andrea Borin (A)

Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.

Italo Porto (I)

IRCCS Policlinico San Martino and University of Genova, Italy.

Francesco Fedele (F)

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.

Massimo Mancone (M)

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.

Gennaro Sardella (G)

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.

Daniela Trabattoni (D)

Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, University of Milan, Italy.

Umberto Barbero (U)

Ospedale Civile SS. Annunziata, Savigliano, Italy.

Cinzia Moncalvo (C)

Ospedale Civile SS. Annunziata, Savigliano, Italy.

Roberto Verardi (R)

Ospedale Maggiore AUSL, Bologna, Italy.

Gianni Casella (G)

Ospedale Maggiore AUSL, Bologna, Italy.

Claudio Montalto (C)

University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Sergio Leonardi (S)

University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Danila Azzolina (D)

Dipartimento Medicina Traslazionale, Università del Piemonte Orientale, Novara, Italy.

Gaetano Maria De Ferrari (GM)

Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy; Department of Medical Sciences, University of Torino, Torino, Italy.

Giuseppe Patti (G)

Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy; Dipartimento Medicina Traslazionale, Università del Piemonte Orientale, Novara, Italy. Electronic address: giuseppe.patti@uniupo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH